The Evaluation of Oxidative Stress Parameters in Serum Patients with Relapsing-Remitting Multiple Sclerosis Treated with II-Line Immunomodulatory Therapy.
Bożena AdamczykSławomir WawrzyniakSławomir KasperczykMonika Adamczyk-SowaPublished in: Oxidative medicine and cellular longevity (2017)
The II-line immunomodulatory treatment decreased OS particularly among women. No difference in OS levels was observed between II-line therapy and IFN beta.